Incentive Stock Option AgreementIncentive Stock Option Agreement • March 24th, 2022 • Inmune Bio, Inc. • Biological products, (no disgnostic substances) • Nevada
This Incentive Stock Option Agreement (this “Agreement”) is made and entered into as of March 21, 2022 by and between INmune Bio, Inc., a Nevada corporation (the “Company”) and (the “Participant”).
INMUNE BIO, INC. Nonqualified Stock Option AgreementNonqualified Stock Option Agreement • March 24th, 2022 • Inmune Bio, Inc. • Biological products, (no disgnostic substances)
This NONQUALIFIED STOCK OPTION AGREEMENT (this “Agreement”), made and entered into on the 21st day of March 2022, by and between (the “Participant”) and INmune Bio, Inc., a Nevada corporation (the “Company”), sets forth the terms and conditions of stock options issued to the Participant by the Compensation Committee of the Board of Directors of the Company on March 21, 2022 (the “Grant Date”) pursuant to the Company's 2021 Stock Incentive Plan (the “Plan”) and this Agreement, which options have been approved by the Company’s Board of Directors. Any capitalized terms used but not defined herein shall have the meaning prescribed in Annex A or in the Plan.
